Kezar Life Sciences, Inc.
KZR
$3.96
-$0.04-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.70M | -16.56M | -20.22M | -20.31M | -21.55M |
| Total Depreciation and Amortization | 243.00K | 251.00K | 259.00K | 260.00K | 261.00K |
| Total Amortization of Deferred Charges | 42.00K | 159.00K | 66.00K | 64.00K | 65.00K |
| Total Other Non-Cash Items | 1.83M | 2.09M | 2.40M | 1.96M | 3.25M |
| Change in Net Operating Assets | -1.21M | -3.14M | 668.00K | 536.00K | 945.00K |
| Cash from Operations | -12.80M | -17.19M | -16.83M | -17.49M | -17.03M |
| Capital Expenditure | 0.00 | -8.00K | -11.00K | -18.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.40M | 13.75M | 23.76M | 24.08M | 12.22M |
| Cash from Investing | 11.40M | 13.74M | 23.74M | 24.06M | 12.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.30M | -1.30M | -- | -- | -- |
| Issuance of Common Stock | 35.00K | -- | 47.00K | 0.00 | 56.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.27M | -1.30M | 47.00K | 0.00 | 56.00K |
| Foreign Exchange rate Adjustments | 32.00K | 5.00K | -75.00K | 16.00K | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.64M | -4.75M | 6.89M | 6.58M | -4.76M |